Log in with your email address username.

×

[Department of Error] Department of Error

Wallace DJ, Furie RA, Tanaka Y, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2018; 392: 222–31—The appendix of this Article has been corrected as of Aug 9, 2018.

email